MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0002422
Hiral Labs Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹66.46 Cr
▲ 6% YoY
Net profit · FY 2025
₹9.66 Cr
Net margin 14.5%
EBITDA · FY 2025
₹14.63 Cr
EBITDA margin 22%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹6.98 Cr
Issued & subscribed
Open charges
₹29 Cr
Satisfied ₹7.2 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
243
Provident fund records
About Hiral Labs Limited
Data last updated:
Hiral Labs Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2000PLC038759. Its GSTIN is 05AAACH9991E1ZF (Uttarakhand).
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.98 Cr. It is led by directors including Amit Ramavtar Jajoo and Fahed Ali Haider Ali Saiyed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 26 Sahe Alam Societynr N V School Sahe – Alam, Ahmedabad, Gujarat, India – 380028.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.46 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹9.66 Cr (net margin 14.5%) and EBITDA of ₹14.63 Cr (EBITDA margin 22%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 14% over five years.
The company has about 243 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Hiral Labs and Hiral Health. As per MCA filings, the company has open charges of ₹29 Cr and satisfied charges of ₹7.2 Cr on record. Court records list 14 cases involving the company, including 14 filed against it; 3 cases are pending.
Hiral Labs Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0002422). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hirallabs.com.
Company details
CIN U24231GJ2000PLC038759
Registration Number 038759
Incorporation Date 09 October 2000
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0002422
Key People
Amit Ramavtar Jajoo Director Fahed Ali Haider Ali Saiyed Director Haiderali Munavarli Saiyed Director Recognitions & Rankings of Hiral Labs
Contact details
Hiral Labs Limited's registered office is in Ahmedabad, Gujarat. Its website is hirallabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address26 Sahe Alam Societynr N V School Sahe – Alam, Ahmedabad, Gujarat, India – 380028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hiral Labs Limited, buy the company report.
Comprehensive company report
Hiral Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hiral Labs operates two associated brands: Hiral Labs and Hiral Health. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and nutraceutical manufacturing in India. | hirallabs.com | |
| Nutraceutical and health supplement manufacturing focused on premium quality products. | hiralhealth.com |
Business activity
The main business activity of Hiral Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hiral Labs Limited, buy the company report.
Financials of Hiral Labs Limited
FY 2025 filings availableHiral Labs Limited reported revenue of ₹66.46 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹66.46 Cr ▲ 6%
Net profit · FY 2025
₹9.66 Cr margin 14.5%
EBITDA · FY 2025
₹14.63 Cr margin 22%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 12%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 17%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 6% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.63 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22% | ||||
| Net Profit Margin | 14.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hiral Labs Limited, buy the company report.
Board of directors of Hiral Labs Limited
Hiral Labs has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Ramavtar Jajoo Also directs: Harnava Tex Private Limited, Acube Tradelink Private Limited | Director | 25 May 2017 | 9 Years 5 Months | Current |
| Fahed Ali Haider Ali Saiyed Also directs: Raali Lifescience Private Limited | Director | 17 Jan 2022 | 4 Years 9 Months | Current |
| Haiderali Munavarli Saiyed Also directs: Raali Lifescience Private Limited | Director | 09 Oct 2000 | 26 Years 0 Months | Current |
| Suraj Bhan Sharma | Director | 28 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Hiral Labs Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmax India Private Limited | ₹66.65 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Swefn Pharmaceuticals Private Limited | ₹66.63 Cr (FY 2025) | 9.0% | Moraiya, Gujarat, India | |||
| Merril Pharma Private Limited | ₹66.57 Cr (FY 2025) | 25.0% | Ahmedabad, Gujarat, India | |||
| Hiral Labs Limitedthis company | ₹66.46 Cr (FY 2025) | ₹9.66 Cr | 14.5% | 6.0% | 243 | Ahmedabad, Gujarat, India |
| Skyec Drugs and Pharmaceuticals Private Limited | ₹66.27 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Medizen Labs Private Limited | ₹66.2 Cr (FY 2023) | 39.0% | Bangalore, Karnataka, India | |||
| Bestochem Formulations (India) Limited | ₹66.17 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Maxmed Life Sciences Private Limited | ₹66.13 Cr (FY 2023) | -10.0% | Delhi, India |
To see the full peer comparison of Hiral Labs Limited, buy the company report.
Auditor
Hiral Labs Limited is audited by PRAKASH BHAVSAR & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAKASH BHAVSAR & ASSOCIATES | FY 2024 | 108072W |
Shareholding
The shareholding of Hiral Labs Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hiral Labs Limited, buy the company report.
Charges & borrowings
Open charges
₹29 Cr
Satisfied charges
₹7.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2018 | 100182704 | Axis Bank Limited | ₹29 Cr | Open | |
| 25 Jul 2017 | 100153526 | Others | ₹1 Cr | Satisfied | |
| 27 Aug 2012 | 10413540 | Axis Bank | ₹1 Cr | Satisfied | |
| 08 Mar 2010 | 10215337 | Axis Bank Limited | ₹1.78 Cr | Satisfied | |
| 05 Mar 2010 | 10215284 | Axis Bank Limited | ₹1.9 Cr | Satisfied |
To see the full charge records of Hiral Labs Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Hiral Labs Limited has 14 court cases on record: 14 filed against it. 3 cases are pending and 11 are disposed.
Total cases
14
Filed against the company
14
Pending
3
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 2 |
| High courts | 6 | 6 | 1 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by Axis Bank Ltd. Through Arpit Shukla | Pending |
| District court, Nagpur, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by Sun Pharmaceutical Industries | Disposed |
To see the full case history of Hiral Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hiral Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hiral Labs Limited has a workforce of 243 employees on its EPFO records as of Mar 10, 2025, across 1 active EPFO establishment.
Employee count
243
Active EPFO establishments
1
Employee growth
10.96%
GST
Hiral Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACH9991E1ZF | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hiral Labs Limited, buy the company report.
Recent activity
Hiral Labs Limited has 9 board changes on record since 2000: 4 appointments and 5 cessations. The latest: Suraj Bhan Sharma ceased to be Additional Director on 23 Dec 2025.
Ceased
Suraj Bhan Sharma ceased to be Additional Director.
AGM
Hiral Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Suraj Bhan Sharma was appointed as Director.
Filing
Hiral Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited of Rs. 29.00 Cr registered on 05 May 2018 with Charge ID 100182704 was modified on 20 Nov 2024.
Ceased
Fahed Ali Haider Ali Saiyed ceased to be Additional Director.
Appointed
Fahed Ali Haider Ali Saiyed was appointed as Director.
Ceased
Rumana Haiderali Saiyed ceased to be Director.
Charges
A charge registered on 27 Aug 2012 via Charge ID 10413540 with Axis Bank was fully satisfied on 05 Feb 2019.
Charges
A charge registered on 08 Mar 2010 via Charge ID 10215337 with Axis Bank Limited was fully satisfied on 05 Feb 2019.
Charges
A charge registered on 05 Mar 2010 via Charge ID 10215284 with Axis Bank Limited was fully satisfied on 05 Feb 2019.
Charges
A charge registered on 25 Jul 2017 via Charge ID 100153526 with Others was fully satisfied on 09 May 2018.
17 earlier events are in the company report.
Frequently asked questions
Hiral Labs is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2000 (26+ years old) and is registered under CIN U24231GJ2000PLC038759.
Hiral Labs has 4 current directors:
- Amit Ramavtar Jajoo - Director
- Fahed Ali Haider Ali Saiyed - Director
- Haiderali Munavarli Saiyed - Director
- Suraj Bhan Sharma - Director
The latest financial statements of Hiral Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hiral Labs is 05AAACH9991E1ZF, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Hiral Labs is U24231GJ2000PLC038759. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hiral Labs has 14 court cases on record: 14 filed against it. 3 are pending. Most are in the district courts.
Hiral Labs was incorporated on 09 October 2000, making it 26+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Hiral Labs by revenue are Pharmax India Private Limited, Swefn Pharmaceuticals Private Limited, Merril Pharma Private Limited, Skyec Drugs and Pharmaceuticals Private Limited, Medizen Labs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suraj Bhan Sharma ceased to be Additional Director on 23 Dec 2025. Suraj Bhan Sharma was appointed as Director on 28 Aug 2025. Fahed Ali Haider Ali Saiyed ceased to be Additional Director on 29 Sep 2023. Hiral Labs has 9 board changes on record in total.
Yes, Hiral Labs is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0002422).
Hiral Labs can be reached through the website hirallabs.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages